PDE5A and Priapism: Preclinical evidence demonstrates that strategies aimed at restoring redox homeostasis, enhancing endothelial NO signaling, and normalizing phosphodiesterase type 5 (PDE5) expression effectively attenuate the priapism phenotype, highlighting oxidative stress as a therapeutic target [9,10,11,12,13].